Vigabratin monotherapy in management of west's syndrome;Uso de monoterapia con vigabatrina en el tratamiento sindrome de west

Revista de Neurologia

Volumn 25, Issue 145, 1997, Pages 1365-1368

  Rufo, M ^a,b   Santiago, C ^a   Castro, E ^a   Ocana O ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b NONE   (Spain)

Author keywords

Monotherapy; Spasms infantile; Vigabatrine; West syndrome

Indexed keywords

VIGABATRIN;

ANTICONVULSANT THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HYPERACTIVITY; INFANT; MALE; PRESCHOOL CHILD; TREATMENT OUTCOME; WEST SYNDROME;

ADRENOCORTICOTROPIC HORMONE; ANTICONVULSANTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT; MALE; PSYCHOMOTOR DISORDERS; SPASMS, INFANTILE; VIGABATRIN;

EID: 0030848492     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Grant SM, Heel RC. Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs 1991; 41: 889-926.
2. Dulac O, Chiron C, Luna D. Vigabatrin in childhood epilepsy. Child Neurol 1991; 6: 2530-7.
3. Livingston JH, Beaumont D, Arzimanoglou A, Aicardi J. Vigabatrin in the treatment of epilepsy in children. Br J Clin Pharmacol 1989; 27: 1095-125.
4. Luna D, Dulac O, Pajot N, Beaumont D. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study. Epilepsia 1989; 30: 430-7.
5. Herranz JL, Arteaga R, Farr IN, Valdizan E, Beaumont D, Armijo J. Dose-response study of vigabatrin in children with refractory epilepsy. J Child Neurol 1991; 6 (Suppl 2): 45-51.
6. Chiron L, Dulac O, Luna D, Palacios L. Vigabatrin in infantile spasms. Lancet 1990; 10: 363-4.
7. Vles JSH, van der Heyden AMH, Ghijs A, Troost J. Vigabatrin in the treatment of infantile spasms. Neuropediatrics 1993; 24: 230-1.
8. Aicardi J, Chairman and the Coordinating Peer Review Group, the European IS Vigabatrin group (*The Wolfson Centre, Mecklenburgh Square, London, U.K.). European Experience with Use of Vigabatrin as First-Line Monotherapy in Infantile Spasms. Epilepsia 1995; 36 (Suppl 3): S102.
9. Herranz JL, Campos J, Casas C, et al. Spanish experience with efficacy and tolerability of vigabatrin in 197 children with refractory epilepsy. Epilepsia 1995; (Suppl 3): S103.
10. Michelucci R, Tassinari CA. Response to vigabatrin in relation to seizure type. Br J Clin Pharmacol 1989; 27: 119S-24S.
11. Mumford JP, Dam M. Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol 1989; 27: 101S-107S.
12. Kalvainen R, Keranen T, Riekkinen PJ. Place of newer antiepileptic drugs in the treatment of epilepsy. Drugs 1993; 46: 1009-24.
13. Ring HA, Reynolds EH. Vigabatrin. In Pedley TA, Meldrum BS, eds. Recents Advances in Epilepsy. Edinburgh: Churchill Livingstone; 1992. p. 177-95.
14. Aicardi J. Tratamiento de los espasmos infantiles con Vigabatrina. Acta Neuropediatr 1996; 2: 8-11.
15. Aicardi J, Chevrie JJ. Les spasmes infantiles. Arch Franc Pediatr 1978; 35: 1015-23.
16. Cavazzuti GB. Infantile spasms with hypsarhythmia. In Lugaresi E, Pazzaglia P, Tassinari CA, eds. Evolution and prognosis of epilepsies. Bologna: Aulo Gaggi; 1973. p. 109-17.
17. Chiron C, Dumas C, Dulac O, et al. Vigabatrin versus ACTH in the treatment of infantile spasms. Epilepsia 1995; (Suppl 3): S265.